Orange Grove Bio and Cincinnati Children’s Hospital Medical Center Establish Collaboration

The following excerpt was taken from Globe Newswire -- continue reading here.

"Orange Grove Bio, a preclinical drug investment and development firm, and Cincinnati Children’s Hospital Medical Center today announced the establishment of a collaboration designed to advance the development and commercialization of novel therapeutics by supporting the translation of scientific discoveries made by researchers at Cincinnati Children’s. The collaboration aims to increase entrepreneurship and education as well as boost promising technologies emerging from Cincinnati Children’s. These efforts will be focused in the areas of autoimmune and inflammatory diseases, oncology, and cell and gene therapies."